Generic Medicines Working Group identifies priorities

Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. The Generic Medicines Working Group, which was established under the Strategic Agreement signed by the Minister for Heath, Sussan Ley, and the Generic and Biosimilar